These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 17156479)

  • 61. Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
    Jiménez-Ruiz CA; Fagerström KO
    Monaldi Arch Chest Dis; 2013 Mar; 79(1):27-32. PubMed ID: 23741943
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis.
    Deng X; Shang X; Guo K; Zhou L; Wang Y; Wu Y; Liang S; E F; Liu W; Wang Z; Li X; Yang K
    Addict Biol; 2023 Aug; 28(8):e13303. PubMed ID: 37500482
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Smoking reduction interventions for smoking cessation.
    Lindson N; Klemperer E; Hong B; Ordóñez-Mena JM; Aveyard P
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013183. PubMed ID: 31565800
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A preliminary benefit-risk assessment of varenicline in smoking cessation.
    Cahill K; Stead L; Lancaster T
    Drug Saf; 2009; 32(2):119-35. PubMed ID: 19236119
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interventions for preoperative smoking cessation.
    Thomsen T; Villebro N; Møller AM
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD002294. PubMed ID: 24671929
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.
    Evins AE; Benowitz NL; West R; Russ C; McRae T; Lawrence D; Krishen A; St Aubin L; Maravic MC; Anthenelli RM
    J Clin Psychopharmacol; 2019; 39(2):108-116. PubMed ID: 30811371
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.
    Xenakis JG; Kinter ET; Ishak KJ; Ward AJ; Marton JP; Willke RJ; Davies S; Caro JJ
    Pharmacoeconomics; 2011 Jun; 29(6):497-510. PubMed ID: 21452908
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Smoking cessation interventions for smokers with current or past depression.
    van der Meer RM; Willemsen MC; Smit F; Cuijpers P
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Smoking cessation: Pharmacological strategies different from standard treatments].
    Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
    Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 'Real-world' effectiveness of smoking cessation treatments: a population study.
    Kotz D; Brown J; West R
    Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
    Roberts E; Eden Evins A; McNeill A; Robson D
    Addiction; 2016 Apr; 111(4):599-612. PubMed ID: 26594837
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relapse prevention interventions for smoking cessation.
    Hajek P; Stead LF; West R; Jarvis M; Hartmann-Boyce J; Lancaster T
    Cochrane Database Syst Rev; 2013 Aug; (8):CD003999. PubMed ID: 23963584
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo DM; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Addiction; 2022 Apr; 117(4):861-876. PubMed ID: 34636108
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Varenicline: new drug. Smoking cessation: no better than nicotine.
    Prescrire Int; 2006 Dec; 15(86):210-2. PubMed ID: 17165237
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
    Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
    JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
    Robles GI; Singh-Franco D; Ghin HL
    Clin Ther; 2008 May; 30(5):800-12. PubMed ID: 18555928
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan.
    Hsueh KC; Hsueh SC; Chou MY; Pan LF; Tu MS; McEwen A; West R
    Psychopharmacology (Berl); 2014 Jul; 231(14):2819-23. PubMed ID: 24522334
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis.
    Guo K; Zhou L; Shang X; Yang C; E F; Wang Y; Xu M; Wu Y; Li Y; Li M; Yang K; Li X
    Drug Alcohol Depend; 2022 Dec; 241():109672. PubMed ID: 36332593
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Smoking cessation and COPD.
    Tønnesen P
    Eur Respir Rev; 2013 Mar; 22(127):37-43. PubMed ID: 23457163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.